Abstract
The Italian publicly funded National Health Service (NHS) provides universal health care, mainly free of charge, to all NHS beneficiaries, that is, the whole Italian population. The NHS has three levels of management. At the national level, the health ministry is responsible for upholding citizens’ rights to health care and its main aim is to define the so-called essential levels of health care, i.e., the services that the NHS must supply free of charge after payment of a registration and maintenance fee.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alacqua M, Trifirò G, Spina E et al (2009) Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003–2005. Epilepsy Res 85(1):107–113. https://doi.org/10.1016/j.eplepsyres.2009.03.002
Arcoraci V, Santoni L, Ferrara R et al (2014) Effect of an educational program in primary care: the case of lipid control in cardio-cerebrovascular prevention. Int J Immunopathol Pharmacol 27(3):351–363. https://doi.org/10.1177/039463201402700305
Belleudi V, Trotta F, Addis A et al (2019) Effectiveness and safety of switching originator and biosimilar epoetins in patients with chronic kidney disease in a large-scale italian cohort study. Drug Saf 42(12):1437–1447. https://doi.org/10.1007/s40264-019-00845-y
Ferrajolo C, Arcoraci V, Sullo MG et al (2014) Pattern of statin use in southern Italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment? PLoS ONE 9(7):e102146. https://doi.org/10.1371/journal.pone.0102146
Ghirardi A, Di Bari M, Zambon A et al (2014a) Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study. Eur J Clin Pharmacol 70(9):1129–1137. https://doi.org/10.1007/s00228-014-1708-8
Ghirardi A, Scotti L, Vedova GD et al (2014b) Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study. BMC Gastroenterol 14:5. https://doi.org/10.1186/1471-230x-14-5
Guerriero F, Orlando V, Tari DU et al (2015) How healthy is community-dwelling elderly population? Results from Southern Italy. Transl Med UniSa 13:59–64
Ingrasciotta Y, Sultana J, Giorgianni F et al (2014) The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy. PLoS ONE 9(2):e89072. https://doi.org/10.1371/journal.pone.0089072
Ingrasciotta Y, Sultana J, Giorgianni F et al (2015) Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study. PLoS ONE 10(4):e0122899. https://doi.org/10.1371/journal.pone.0122899
Ingrasciotta Y, Belleudi V, Trotta F et al (2019) In search of predictors of switching between erythropoiesis-stimulating agents in clinical practice: a multi-regional cohort study. Biodrugs. https://doi.org/10.1007/s40259-019-00385-y
Lapi F, Cipriani F, Caputi AP et al (2013) Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures. Osteoporos Int 24(2):697–705. https://doi.org/10.1007/s00198-012-2013-y
Marciano I, Ingrasciotta Y, Giorgianni F et al (2018) Pattern of use of biosimilar and originator somatropin in Italy: a population-based multiple databases study during the years 2009–2014. Front Endocrinol (Lausanne) 9:95. https://doi.org/10.3389/fendo.2018.00095
Oteri A, Trifirò G, Gagliostro MS et al (2010) Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004–07. Br J Clin Pharmacol 70(4):514–522. https://doi.org/10.1111/j.1365-2125.2010.03619.x
Piacentini N, Trifirò G, Tari M et al (2005) Statin-macrolide interaction risk: a population-based study throughout a general practice database. Eur J Clin Pharmacol 61(8):615–620. https://doi.org/10.1007/s00228-005-0972-z
Rafaniello C, Arcoraci V, Ferrajolo C et al (2015) Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: a population-based study. Diabetes Res Clin Pract 108(1):157–163. https://doi.org/10.1016/j.diabres.2014.12.007
Sultana J, Musazzi UM, Ingrasciotta Y et al (2015) Medication is an additional source of phosphate intake in chronic kidney disease patients. Nutr Metab Cardiovasc Dis 25(10):959–967. https://doi.org/10.1016/j.numecd.2015.06.001
Sultana J, Hurtado I, Bejarano-Quisoboni D et al (2019) Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries. Eur J Clin Pharmacol 75(7):1005–1015. https://doi.org/10.1007/s00228-019-02654-9
Trifirò G, Barbui C, Spina E et al (2007) Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003–2004. Pharmacoepidemiol Drug Saf 16(5):552–559. https://doi.org/10.1002/pds.1303
Trifirò G, Alacqua M, Corrao S et al (2008a) Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. J Am Geriatr Soc 56(1):175–177. https://doi.org/10.1111/j.1532-5415.2007.01486.x
Trifirò G, Savica R, Morgante L et al (2008b) Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003–2005. Parkinsonism Relat Disord 14(5):420–425. https://doi.org/10.1016/j.parkreldis.2007.10.010
Trifirò G, Italiano D, Alibrandi A et al (2013) Effects of L’Aquila earthquake on the prescribing pattern of antidepressant and antipsychotic drugs. Int J Clin Pharm 35(6):1053–1062. https://doi.org/10.1007/s11096-013-9822-8
Trifirò G, Sultana J, Giorgianni F et al (2014) Chronic kidney disease requiring healthcare services: a new approach to evaluate epidemiology of renal disease. Biomed Res Int 2014:268362. https://doi.org/10.1155/2014/268362
Trifirò G, Parrino F, Pizzimenti V et al (2016) The management of diabetes mellitus in patients with chronic kidney disease: a population-based study in Southern Italy. Clin Drug Investig 36(3):203–212. https://doi.org/10.1007/s40261-015-0367-6
Trifirò G, Gini R, Barone-Adesi F et al (2019) The role of European Healthcare Databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand? Drug Saf 42(3):347–363. https://doi.org/10.1007/s40264-018-0732-5
Viola E, Trifirò G, Ingrasciotta Y et al (2016) Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study. Expert Opin Drug Saf 15(sup 2):61–67. https://doi.org/10.1080/14740338.2016.1221401
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Trifirò, G., Ientile, V., Sultana, J., Tari, M. (2021). Caserta Record Linkage Database. In: Sturkenboom, M., Schink, T. (eds) Databases for Pharmacoepidemiological Research. Springer Series on Epidemiology and Public Health. Springer, Cham. https://doi.org/10.1007/978-3-030-51455-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-51455-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51454-9
Online ISBN: 978-3-030-51455-6
eBook Packages: MedicineMedicine (R0)